Ann: Extension of Voluntary Suspension, page-473

First 473 Last

Share
Profile

Follow
delboy007

4,861 Posts.

991

27/11/20

17:23

Post #: 49198514
Share

Originally posted by Immetoday ↑

2-3 cent mark without doubt.

MTN is NOT worth $20m....where did you get that figure from????
Their first and only payment to date from MTN equates to around $10K a month. MTN have now finished their advertising spend on the platform so any growth now will be organic. It'll never be worth $20m, be very lucky to break $1m per annum!

.....and pretty clear on the guaranteed 100,000 subscribers.
You need to read the full ann....not pull out one line....
TIM guarantees a minimum of 100,000 subscribers will subscribe to the platform within 6 months
from launch date
● If the target is not reached, TIM will pay Emerge 50% of the cost of prizes put up by Emerge. If
the Agreement is terminated prior to the end of the 12 months and the target is not reached, TIM
will pay Emerge 50% of the cost of prizes put up by Emerge until the end of the contract

If target is not reached there is no guarantee....basically they have said "we'll get subscribers and pay you money but id we don't we'll give you back half the money you already spent betting on the fact we said we could get subscribers".

But, as we all know....CROWD1 owes money everywhere so good luck getting the $'s!

Basically EM1 has entered an agreement that the other party can cancel if they don't do anything and for this they have the pleasure of paying 50% of money spent on prizes that didn't need to be spent to start with.....2-3 may be generous!

Expand

There's no words for that Bullsheet post

So I'll just laugh

Very funny... immune day

Great weekend to all.
One more week in suspension and she'll be ready

EM1 Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 313 more messages in this thread...

First 473 Last

Add SP8 (ASX) to my watchlist

(20min delay)
Last 0.7¢		Change 0.000(0.00%)		Mkt cap ! $7.479M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
4	1787667	0.6¢

Sellers (Offers)

Price($)	Vol.	No.
0.7¢	1956011	5

View Market Depth

No.	Vol.	Price($)
4	1787667	0.006
4	1026833	0.005
4	9300000	0.004
3	2300000	0.003
2	2000000	0.002

Price($)	Vol.	No.
0.007	1956011	5
0.008	2833808	5
0.009	14606480	6
0.010	18193194	6
0.011	3000000	2

Last trade - 10.08am 04/10/2024 (20 minute delay)

SP8 (ASX) Chart

Day chart unavailable

Ann: Extension of Voluntary Suspension, page-473

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Extension of Voluntary Suspension, page-473

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News